Artepillin C (3,5-diprenyl-4-hydroxycinnamic acid) sensitizes LNCaP prostate cancer cells to TRAIL-induced apoptosis

International Journal of Oncology

Volumn 41, Issue 3, 2012, Pages 818-828

  Szliszka, Ewelina ^a   Zydowicz, Grzegorz ^a   Mizgala, Elzbieta ^a   Krol, Wojciech ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Apoptosis; Artepillin C; Chemoprevention; Green propolis; Prostate cancer; Tumour necrosis factor related apoptosis inducing ligand

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; ARTEPILLIN C; CASPASE 3; CASPASE 8; DEATH RECEPTOR 4; DEATH RECEPTOR 5; FLUORESCEIN ISOTHIOCYANATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE; LIPOCORTIN 5; PHENOL DERIVATIVE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CHEMOSENSITIZATION; COLORIMETRY; CONTROLLED STUDY; DRUG SCREENING; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN INDUCTION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASE 3; CASPASE 8; CELL LINE, TUMOR; HUMANS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; NF-KAPPA B; NUCLEIC ACID SYNTHESIS INHIBITORS; PHENYLPROPIONATES; PROSTATIC NEOPLASMS; RECEPTORS, DEATH DOMAIN; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84864967794     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1527     Document Type: Article

References (54)

1. Lee JY, Huerta-Yepez S, Vega M, Baritaki S, Spandidos DA and Bonavida B: The NO TRAIL to YES TRAIL in cancer therapy (Review). Int J Oncol 31: 685-691, 2007.
2. Voelkel-Johnson C: TRAIL-mediated signaling in prostate, bladder and renal cancer. Nat Rev Urol 8: 417-427, 2011.
3. Baritaki S, Katsman A, Chatterjee D, Yeung KC, Spandidos DA and Bonavida B: Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation. J Immunol 179: 5441-5453, 2007.
4. Baritaki S, Huerta-Yepez S, Sakai T, Spandidos DA and Bonavida B: Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1. Mol Cancer Ther 6: 1387-1399, 2007. (Pubitemid 46712002)
5. Baritaki S, Suzuki E, Umezawa K, Spandidos DA, Berenson J, Daniels TR, Penichet ML, Jazirehi AR, Palladino M and Bonavida B: Inhibition of Yin Yang 1-dependent repressor activity of DR5 transcription and expression by the novel proteasome inhibitor NPI-0052 contributes to its TRAIL-enhanced apoptosis in cancer cells. J Immunol 180: 6199-6210, 2008.
6. Szliszka E and Krol W: The role of dietary polyphenols in tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis for cancer chemoprevention. Eur J Cancer Prev 20: 63-69, 2011.
7. Szliszka E, Bronikowska J, Majcher A, Miszkiewicz J and Krol W: Enhanced sensitivity of hormone-refractory prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated cytotoxicity by taxanes. CEJ Urol 62: 29-34, 2009.
8. Szliszka E, Bronikowska J, Czuba ZP and Krol W: Isoflavones augment the effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) on prostate cancer cells. CEJ Urol 63: 182-186, 2010.
9. Szliszka E, Gebka J, Bronikowska J and Krol W: Dietary flavones enhance the effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) on bladder cancer cells. CEJ Urol 63: 138-143, 2010.
10. Lee SJ, Noh HJ, Sung EG, Song IH, Kim JY, Kwon TK and Lee TJ: Berberine sensitizes TRAIL-induced apoptosis through proteasome-mediated downregulation of c-FLIP and Mcl-1 proteins. Int J Oncol 38: 485-492, 2011.
11. Fujiwara J, Sowa Y, Horinaka M, Koyama M, Wakada M, Miki T and Sakai T: The anti-obesity drug orlistat promotes sensitivity to TRAIL by two different pathways in hormone-refractory prostate cancer cells. Int J Oncol 40: 1483-1491, 2012.
12. Horinaka M, Yoshida T, Shiraishi T, Nakata S, Wakada M and Sakai T: The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand. Mol Cancer Ther 5: 945-951, 2006. (Pubitemid 43724594)
13. Jung YH, Heo J, Lee YJ, Kwon TK and Kim YH: Quercetin enhances TRAIL-mediated apoptosis in prostate cancer cells via increased protein stability of death receptor 5. Life Sci 86: 351-357, 2010.
14. Szliszka E, Czuba ZP, Mazur B, Paradysz A and Krol W: Chalcones and dihydrochalcones augment TRAIL-mediated apoptosis in prostate cancer cells. Molecules 15: 5336-5353, 2010.
15. Szliszka E, Czuba ZP, Sedek L, Paradysz A and Krol W: Enhanced TRAIL-mediated apoptosis in prostate cancer cells by the bioactive compounds neobavaisoflavone and psoralidin isolated from Psoralea corylifolia. Pharmacol Rep 63: 139-148, 2011.
16. Szliszka E, Czuba ZP, Bronikowska J, Mertas A, Paradysz A and Krol W: Ethanolic extract of propolis (EEP) augments TRAIL-induced apoptotic death in prostate cancer cells. Evid Based Complement Alternat Med 2011: 535172, 2011.
17. Szliszka E, Zydowicz G, Janoszka B, Dobosz C, Kowalczyk-Ziomek G and Krol W: Ethanolic extract of Brazilian green propolis sensitizes prostate cancer cells to TRAIL-induced apoptosis. Int J Oncol 38: 941-953, 2011.
18. Szliszka E and Krol W: Soy isoflavones augment the effect of TRAIL-mediated apoptotic death in prostate cancer cells. Oncol Rep 26: 533-541, 2011.
19. Szliszka E, Helewski KJ, Mizgala E and Krol W: The dietary flavonol fisetin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells. Int J Oncol 39: 771-779, 2011.
20. Szliszka E, Czuba ZP, Mertas A, Paradysz A and Krol W: The dietary isoflavone biochanin-A sensitizes prostate cancer cells to TRAIL-induced apoptosis. Urol Oncol http://dx.doi.org/10.1016/j.urolonc.2011.01.019, 2011.
21. Park YK, Paredes-Guzman JF, Aguiar CL, Alencar SM and Fujiwara FY: Chemical constituents in Baccharis dracunculifolia as the main botanical origin of southeastern Brazilian propolis. J Agric Food Chem 52: 1100-1113, 2004.
22. Matsuda AH and de Almeida-Muradian LB: Validated method for the quantification of artepillin C in Brazilian propolis. Phytochem Anal 19: 179-183, 2008. (Pubitemid 351425320)
23. de Sousa JP, Leite MF, Jorge RF, Resende DO, da Silva Filho AA, Furtado NA, Soares AE, Spadaro AC, de Magalhaes PM and Bastos JK: Seasonality role on the phenolics from cultivated Baccharis dracunculifolia. Evid Based Complement Alternat Med 2011: 464289, 2011.
24. Matsuno T, Jung SK, Matsumoto Y, Saito M and Morikawa J: Preferential cytotoxicity to tumor cells of 3,5-diprenyl- 4-hydroxycinnamic acid (artepillin C) isolated from propolis. Anticancer Res 17: 3565-3568, 1997. (Pubitemid 27522325)
25. Kimoto T, Arai S, Kohguchi M, Aga M, Nomura Y, Micallef MJ, Kurimoto M and Mito K: Apoptosis and suppression of tumor growth by artepillin C extracted from Brazilian propolis. Cancer Detect Prev 22: 506-515, 1998. (Pubitemid 28537432)
26. Kimoto T, Aga M, Hino K, Koya-Miyata S, Yamamoto Y, Micallef MJ, Hanaya T, Arai S, Ikeda M and Kurimoto M: Apoptosis of human leukemia cells induced by artepillin C, an active ingredient of Brazilian propolis. Anticancer Res 21: 221-228, 2001. (Pubitemid 32267646)
27. Ahn MR, Kunimasa K, Ohta T, Kumazawa S, Kamihira M, Kaji K, Uto Y, Hori H, Nagasawa H and Nakayama T: Suppression of tumor-induced angiogenesis by Brazilian propolis: major component artepillin C inhibits in vitro tube formation and endothelial cell proliferation. Cancer Lett 252: 235-243, 2007. (Pubitemid 46809795)
28. Paulino N, Abreu SR, Uto Y, Koyama D, Nagasawa H, Hori H, Dirsch VM, Vollmar AM, Scremin A and Bretz WA: Anti-inflammatory effects of a bioavailable compound, Artepillin C, in Brazilian propolis. Eur J Pharmacol 587: 296-301, 2008.
29. Ahn MR, Kunimasa K, Kumazawa S, Nakayama T, Kaji K, Uto Y, Hori H, Nagasawa H and Ohta T: Correlation between antiangiogenic activity and antioxidant activity of various components from propolis. Mol Nutr Food Res 53: 643-651, 2009.
30. Izuta H, Narahara Y, Shimazawa M, Mishima S, Kondo S and Hara H: 1,1-diphenyl-2-picrylhydrazyl radical scavenging activity of bee products and their constituents determined by ESR. Biol Pharm Bull 32: 1947-1951, 2009.
31. Messerli SM, Ahn MR, Kunimasa K, Yanagihara M, Tatefuji T, Hashimoto K, Mautner V, Uto Y, Hori H, Kumazawa S, Kaji K, Ohta T and Maruta H: Artepillin C (ARC) in Brazilian green propolis selectively blocks oncogenic PAK1 signaling and suppresses the growth of NF tumors in mice. Phytother Res 23: 423-427, 2009.
32. Simoes-Ambrosio LM, Gregorio LE, Sousa JP, Figueiredo-Rinhel AS, Azzolini AE, Bastos JK and Lucisano-Valim YM: The role of seasonality on the inhibitory effect of Brazilian green propolis on the oxidative metabolism of neutrophils. Fitoterapia 81: 1102-1108, 2010.
33. de Azevedo Bentes Monteiro Neto M, de Souza Lima IM, Furtado RA, Bastos JK, da Silva Filho AA and Tavares DC: Antigenotoxicity of artepillin C in vivo evaluated by the micronucleus and comet assays. J Appl Toxicol 31: 714-719, 2011.
34. Fonseca YM, Marquele-Oliveira F, Vicentini FT, Furtado NA, Sousa JP, Lucisano-Valim YM and Fonseca MJ: Evaluation of the potential of Brazilian propolis against UV-induced oxidative stress. Evid Based Complement Alternat Med 2011: 863917, 2010.
35. Moura SA, Negri G, Salatino A, Lima LD, Dourado LP, Mendes JB, Andrade SP, Ferreira MA and Cara DC: Aqueous extract of Brazilian green propolis: primary components, evaluation of inflammation and wound healing by using subcutaneous implanted sponges. Evid Based Complement Alternat Med 2011: 748283, 2011.
36. Watanabe MA, Amarante MK, Conti BJ and Sforcin JM: Cytotoxic constituents of propolis inducing anticancer effects: a review. J Pharm Pharmacol 63: 1378-1386, 2011.
37. Androutsopoulos VP, Ruparelia K, Arroo RR, Tsatsakis AM and Spandidos DA: CYP1-mediated antiproliferative activity of dietary flavonoids in MDA-MB-468 breast cancer cells. Toxicology 264: 162-170, 2009.
38. Androutsopoulos VP, Papakyriakou A, Vourloumis D, Tsatsakis AM and Spandidos DA: Dietary flavonoids in cancer therapy and prevention: substrates and inhibitors of cytochrome P450 CYP1 enzymes. Pharmacol Ther 126: 9-20, 2010.
39. Androutsopoulos VP, Papakyriakou A, Vourloumis D and Spandidos DA: Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids. Bioorg Med Chem 19: 2842-2849, 2011.
40. Davalli P, Rizzi F, Caldara GF, Davoli S, Corti A, Silva A, Astancolle S, Vitale M, Bettuzzi S, Arcari M and Azzali G: Chronic administration of green tea extract to TRAMP mice induces the collapse of Golgi apparatus in prostate secretory cells and results in alterations of protein post-translational processing. Int J Oncol 39: 1521-1527, 2011.
41. Onoda C, Kuribayashi K, Nirasawa S, Tsuji N, Tanaka M, Kobayashi D, Watanabe N: (-)-Epigallocatechin-3-gallate induces apoptosis in gastric cancer cell lines by down-regulating survivin expression. Int J Oncol 38: 1403-1408, 2011.
42. Teiten MH, Gaascht F, Cronauer M, Henry E, Dicato M and Diederich M: Anti-proliferative potential of curcumin in androgen-dependent prostate cancer cells occurs through modulation of the Wingless signaling pathway. Int J Oncol 38: 603-611, 2011.
43. Miki H, Uehara N, Kimura A, Sasaki T, Yuri T, Yoshizawa K and Tsubura A: Resveratrol induces apoptosis via ROS-triggered autophagy in human colon cancer cells. Int J Oncol 40: 1020-1028, 2012.
44. Marech I, Vacca A, Ranieri G, Gnoni A and Dammacco F: Novel strategies in the treatment of castration-resistant prostate cancer (Review). Int J Oncol 40: 1313-1320, 2012.
45. Venkateswaran V and Klotz LH: Diet and prostate cancer: mechanisms of action and implications for chemoprevention. Nat Rev Urol 7: 442-453, 2010.
46. Bronikowska J, Szliszka E, Czuba ZP, Zwolinski D, Szmydki B and Krol W: The combination of TRAIL and isoflavones enhances apoptosis in cancer cells. Molecules 15: 2000-2015, 2010.
47. Szliszka E, Czuba ZP, Domino M, Mazur B, Zydowicz G and Krol W: Ethanolic extract of propolis (EEP) enhances the apoptosis-inducing potential of TRAIL in cancer cells. Molecules 14: 738-754, 2009.
48. Szliszka E, Skaba D, Czuba ZP and Krol W: Inhibition of inflammatory mediators by neobavaisoflavone in activated RAW264.7 macrophages. Molecules 16: 3701-3712, 2011.
49. Szliszka E, Czuba ZP, Kawczyk-Krupka A, Sieron-Stoltny A, Sieron A and Krol W: Chlorin-based photodynamic therapy enhances the effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in bladder cancer cells. Med Sci Monit 18: BR47-BR53, 2012.
50. Szliszka E, Mazur B, Zydowicz G, Czuba ZP and Krol W: TRAIL-induced apoptosis and expression of death receptor TRAIL-R1 and TRAIL-R2 in bladder cancer cells. Folia Histochem Cytobiol 47: 579-585, 2009.
51. Akao Y, Maruyama H, Matsumoto K, Ohguchi K, Nishizawa K, Sakamoto T, Araki Y, Mishima S and Nozawa Y: Cell growth inhibitory effect of cinnamic acid derivatives from propolis on human tumor cell lines. Biol Pharm Bull 26: 1057-1059, 2003. (Pubitemid 41685442)
52. Yoshida T, Konishi M, Horinaka M, Yasuda T, Goda AE, Taniguchi H, Yano K, Wakada M and Sakai T: Kaempferol sensitizes colon cancer cells to TRAIL-induced apoptosis. Biochem Biophys Res Commun 375: 129-133, 2008.
53. Li X, Wang JN, Huang JM, Xiong XK, Chen MF, Ong CN, Shen HM and Yang XF: Chrysin promotes tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induced apoptosis in human cancer cell lines. Toxicol In Vitro 25: 630-635, 2011.
54. Baritaki S, Militello L, Malaponte G, Spandidos DA, Salcedo M and Bonavida B: The anti-CD20 mAb LFB-R603 interrupts the dysregulated NF-κB/Snail/RKIP/PTEN resistance loop in B-NHL cells: Role in sensitization to TRAIL apoptosis. Int J Oncol 38: 1683-1694, 2011.